Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lebwohl

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2021
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trialR B Warren, M Lebwohl, H Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2020
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trialsL Puig, T-F Tsai, T Bhutani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trialsA Blauvelt, K Reich, M Lebwohl, et al.
Pediatric Dermatology|March 18, 2000
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotypeZ Urbán, S Peyrol, H Plauchu, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of the American Academy of Dermatology|January 1, 1994
Classification of pseudoxanthoma elasticum: report of a consensus conferenceM Lebwohl, K Neldner, F M Pope, et al.
Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 29, 2014
Physician perceptions and experience of current treatment in actinic keratosisE Stockfleth, K Peris, C Guillen, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
The British Journal of Dermatology|March 25, 2021
Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III studyA S Van Voorhees, L Stein Gold, M Lebwohl, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2021
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trialR B Warren, M Lebwohl, H Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2020
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trialsL Puig, T-F Tsai, T Bhutani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trialsA Blauvelt, K Reich, M Lebwohl, et al.
Pediatric Dermatology|March 18, 2000
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotypeZ Urbán, S Peyrol, H Plauchu, et al.
Archives of Dermatology|December 1, 1996
Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled studyD M Pariser, R J Pariser, D Breneman, et al.
Journal of the American Academy of Dermatology|January 1, 1994
Classification of pseudoxanthoma elasticum: report of a consensus conferenceM Lebwohl, K Neldner, F M Pope, et al.
Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 29, 2014
Physician perceptions and experience of current treatment in actinic keratosisE Stockfleth, K Peris, C Guillen, et al.
The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.
The British Journal of Dermatology|March 25, 2021
Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III studyA S Van Voorhees, L Stein Gold, M Lebwohl, et al.
Pageof 18